Collectively, our results reveal that the CAY10683 combined with IM treatment induced apoptosis of CML cells resistant to IM partially through the PI3K/Akt pathway mediated by HDAC2. This evidence concerns the gene AKT1 and chronic myelogenous leukemia, BCR-ABL1 positive.